newsfilter
← Latest News
PR Newswire·

The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"

COAG
  • The Galien Foundation announced the 2026 Prix Galien USA Award nominees on August 13, 2026, celebrating 20 years of recognizing healthcare innovation.
  • Winners will be honored at the awards ceremony on October 29, 2026, at the American Museum of Natural History in New York City.
  • Nominees were selected across four categories: Best Digital Health Solution, Best Medical Technology, Incubators, Accelerators & Equity, & Best Startup.
  • For the Best Medical Technology category, candidates must be FDA approved for marketing within the last five years; sales data are not considered in the selection process.
  • Selection criteria focus exclusively on scientific merit & potential health impact rather than commercial performance.
  • Notable nominees in Best Digital Health Solution include Accumulus Technologies, AEYE Health, Aptar Digital Health, & Intellect.
  • Notable nominees in Best Medical Technology include Abbott, Alcon, Edwards Lifesciences, Johnson & Johnson, & Medtronic.
  • Incubators, Accelerators, & Equity nominees include ANDHealth, Calibr-Skaggs Institute, Mayo Clinic, & Deep Knowledge Group.
  • Best Startup nominees feature over 60 companies including AIVITA Biomedical, Compass Pathways, Insilico Medicine, & Mammoth Biosciences.
  • The 2026 judging committee is chaired by Kenneth C. Frazier & includes executives from Pfizer, Johnson & Johnson, AstraZeneca, & Sanofi.
  • The Prix Galien Foundation was established in Paris in 1970 by Roland Mehl to honor Galen & is regarded as a major biopharmaceutical award equivalent to the Nobel Prize.
  • The foundation currently operates through 16 chapters in over 75 countries with expansion ongoing in China, Singapore, & Australia.
  • The 2025 inaugural Prix Galien Bridges Forum & Patient Summit for Prix Galien USA were held to reinforce the commitment to science without borders.